Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial

被引：0

作者：

Wei, Lai ^{[1
]}

Xie, Qing ^{[2
]}

Hou, Jinlin ^{[3
]}

Tang, Hong ^{[4
]}

Ning, Qin ^{[5
]}

Cheng, Jun ^{[6
]}

Nan, Yuemin ^{[7
]}

Zhang, Lunli ^{[8
]}

Li, Jun ^{[9
]}

Jiang, Jianning ^{[10
]}

McNabb, Brian L. ^{[11
]}

Zhang, Fangqiu ^{[12
]}

Camus, Gregory ^{[13
]}

Mo, Hongmei ^{[13
]}

McNally, John ^{[11
]}

Brainard, Diana M. ^{[11
]}

Subramanian, Mani ^{[11
]}

Gong, Guozhong ^{[14
]}

Mou, Zhuangbo ^{[15
]}

Wu, Shanming ^{[16
]}

Wang, Qui-Qiang ^{[17
]}

Hu, Peng ^{[18
]}

Gao, Yanhang ^{[19
]}

Jia, Jidong ^{[20
]}

Duan, Zhongping ^{[21
]}

机构：

[1] Peking Univ, Peoples Hosp, Beijing, Peoples R China

[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai, Peoples R China

[3] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China

[4] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China

[5] Huanzhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China

[6] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China

[7] Hebei Med Univ, Hosp 3, Shijiazhuang, Hebei, Peoples R China

[8] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China

[9] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China

[10] Guangxi Med Univ, Affiliated Hosp 1, Guangxi, Peoples R China

[11] Gilead Sci Inc, Clin Res, 353 Lakeside Dr, Foster City, CA 94404 USA

[12] Gilead Sci Inc, Biostat, 353 Lakeside Dr, Foster City, CA 94404 USA

[13] Gilead Sci Inc, Virol, 353 Lakeside Dr, Foster City, CA 94404 USA

[14] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China

[15] Jinan Infect Dis Hosp, Jinan, Shandong, Peoples R China

[16] Clin Ctr Shanghai Publ Hlth, Shanghai, Peoples R China

[17] Peking Univ, Hosp 1, Beijing, Peoples R China

[18] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China

[19] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China

[20] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China

[21] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China

来源：

HEPATOLOGY | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1191

引用

页码：642A / 642A

页数：1

共 50 条

[41] Safety and efficacy of the combination Sofosbuvir-Ledipasvir in HCV mono-infected patients from the French Cohort ANRS CO22 HEPATHER [J].

Pol, Stanislas .

HEPATOLOGY, 2017, 66 :582A-582A

[42] Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt [J].

Shiha, Gamal ;

Esmat, Gamal ;

Hassany, Mohamed ;

Soliman, Reham ;

Elbasiony, Mohamed ;

Fouad, Rabab ;

Elsharkawy, Aisha ;

Hammad, Radi ;

Abdel-Razek, Wael ;

Zakareya, Talaat ;

Kersey, Kathryn ;

Massetto, Benedetta ;

Osinusi, Anu ;

Lu, Sophia ;

Brainard, Diana M. ;

McHutchison, John G. ;

Waked, Imam ;

Doss, Wahid .

GUT, 2019, 68 (04) :721-728

[43] 98% SVR12 IN KOREAN AND TAIWANESE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION RECEIVING 12 WEEKS OF LEDIPASVIR/SOFOSBUVIR: RESULTS FROM AN INTERNATIONAL, MULTICENTER PHASE 3 STUDY [J].

Lim, Y. -S. ;

Chuang, W. -L. ;

Ahn, S. -H. ;

Peng, C. -Y. ;

Paik, S. -W. ;

Chien, R. -N. ;

Chu, C. -J. ;

Yang, J. C. ;

Mo, H. ;

Gao, B. ;

Pang, P. S. ;

Knox, S. J. ;

McHutchison, J. G. ;

Lee, Y. -J. ;

Chang, T. -T. ;

Jeong, S. -H. ;

Han, K. -H. ;

Kao, J. -H. .

JOURNAL OF HEPATOLOGY, 2015, 62 :S661-S662

[44] Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial [J].

Tetsuo Takehara ;

Naoya Sakamoto ;

Shuhei Nishiguchi ;

Fusao Ikeda ;

Tomohide Tatsumi ;

Yoshiyuki Ueno ;

Hiroshi Yatsuhashi ;

Yasuhiro Takikawa ;

Tatsuo Kanda ;

Minoru Sakamoto ;

Akihiro Tamori ;

Eiji Mita ;

Kazuaki Chayama ;

Gulan Zhang ;

Shampa De-Oertel ;

Hadas Dvory-Sobol ;

Takuma Matsuda ;

Luisa M. Stamm ;

Diana M. Brainard ;

Yasuhito Tanaka ;

Masayuki Kurosaki .

Journal of Gastroenterology, 2019, 54 :87-95

[45] UTILIZATION OF DAA THERAPIES LEDIPASVIR/SOFOSBUVIR AND SOFOSBUVIR/VELPATASVIR IN PATIENTS WITH GENOTYPE 1 HCV: REAL-WORLD EXPERIENCE FROM THE TRIO NETWORK [J].

Tsai, Naoky ;

Bacon, Bruce ;

Curry, Michael ;

Dieterich, Douglas T. ;

Flamm, Steven L. ;

Kowdley, Kris V. ;

Milligan, Scott ;

Younossi, Zobair M. ;

Afdhal, Nezam H. .

GASTROENTEROLOGY, 2017, 152 (05) :S1091-S1091

[46] Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir plus /- ribavirin in HCV genotype 1-infected patients with a history of bleeding disorders: Results from phase 3 trials [J].

Parruti, Giustino ;

Macedo, Guilherme ;

Baumgarten, Axel ;

Nevens, Frederik ;

Feld, Jordan J. ;

Hezode, Christophe ;

Larsen, Lois M. ;

Shulman, Nancy ;

Vilchez, Regis A. ;

Wedemeyer, Heiner .

HEPATOLOGY, 2015, 62 :754A-755A

[47] Utilization of DAA therapies ledipasvir/sofosbuvir and sofosbuvir/velpatasvir in patients with genotype 1 HCV: real-world experience from the TRIO Network [J].

Tsai, N. ;

Bacon, B. ;

Curry, M. ;

Dieterich, D. ;

Flamm, S. ;

Kowdley, K. ;

Milligan, S. ;

Younossi, Z. ;

Afdhal, N. .

JOURNAL OF HEPATOLOGY, 2017, 66 (01) :S726-S726

[48] Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis [J].

Reddy, K. Rajender ;

Bourliere, Marc ;

Sulkowski, Mark ;

Omata, Masao ;

Zeuzem, Stefan ;

Feld, Jordan J. ;

Lawitz, Eric ;

Marcellin, Patrick ;

Welzel, Tania M. ;

Hyland, Robert ;

Ding, Xiao ;

Yang, Jenny ;

Knox, Steven ;

Pang, Phillip ;

Dvory-Sobol, Hadas ;

Subramanian, G. Mani ;

Symonds, William ;

McHutchison, John G. ;

Mangia, Alessandra ;

Gane, Edward ;

Mizokami, Masashi ;

Pol, Stanislas ;

Afdhal, Nezam .

HEPATOLOGY, 2015, 62 (01) :79-86

[49] Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment [J].

Okubo, Tomomi ;

Atsukawa, Masanori ;

Tsubota, Akihito ;

Toyoda, Hidenori ;

Shimada, Noritomo ;

Abe, Hiroshi ;

Kato, Keizo ;

Hayama, Korenobu ;

Arai, Taeang ;

Nakagawa-Iwashita, Ai ;

Itokawa, Norio ;

Kondo, Chisa ;

Kawamoto, Chiaki ;

Iio, Etsuko ;

Tanaka, Yasuhito ;

Kumada, Takashi ;

Iwakiri, Katsuhiko .

HEPATOLOGY INTERNATIONAL, 2018, 12 (02) :133-142

[50] Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment [J].

Tomomi Okubo ;

Masanori Atsukawa ;

Akihito Tsubota ;

Hidenori Toyoda ;

Noritomo Shimada ;

Hiroshi Abe ;

Keizo Kato ;

Korenobu Hayama ;

Taeang Arai ;

Ai Nakagawa-Iwashita ;

Norio Itokawa ;

Chisa Kondo ;

Chiaki Kawamoto ;

Etsuko Iio ;

Yasuhito Tanaka ;

Takashi Kumada ;

Katsuhiko Iwakiri .

Hepatology International, 2018, 12 :133-142

← 1 2 3 4 5 →